eXmoor Pharma and Siam Bioscience, announced a strategic partnership to build the region’s foremost centre for Cell and Gene Therapy (CGT) development and manufacturing. The collaboration aims to ...
BANGKOK (Reuters) - Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began producing AstraZeneca Plc's COVID-19 vaccine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback